Obesity

Some diabetes medications could help reduce alcohol consumption and alcohol-related health problems, particularly in those with obesity, results of a systematic review published in eClinicalMedicine suggested.

SAN DIEGO — Treatment with glucagon-like peptide-1 receptor agonists significantly reduced alanine aminotransferase among children with metabolic dysfunction-associated steatotic liver disease, especially those with type 2 diabetes.

SAN ANTONIO — Structural racism, as measured by historical redlining, was tied to a higher prevalence of obesity by reducing food access for people from traditionally underrepresented backgrounds, according to a presentation at ObesityWeek.

CHICAGO — Black and Hispanic women who adhered to components of a Mediterranean-style diet were less likely to experience any adverse pregnancy outcome, regardless of overweight or obesity status, researchers reported.

The GLP-1 receptor agonist semaglutide may not only add another therapeutic option for chronic kidney disease, but it could also lead to changes in the way clinicians treat the condition.

Children with obesity have increased risk for type 2 diabetes if they are diagnosed with metabolic dysfunction-associated steatotic liver disease, according to findings published in Diabetes Care.

Greater adherence to American dietary guideline recommendations appeared linked with reduced likelihood of prostate cancer progression among men undergoing active surveillance, study results showed.

CHICAGO — People living in historically redlined neighborhoods with poor access to healthy foods were more likely to have type 2 diabetes, hypertension, coronary heart disease and obesity, researchers reported.

SAN ANTONIO — Obesity medications, regardless of class or generation, were associated with reduced alcohol intake among individuals participating in a telehealth weight-loss program, a speaker reported.

CHICAGO — In adults with HF with preserved ejection fraction and obesity, treatment with tirzepatide cut risk for CV death or worsening HF by 38% compared with placebo, with a parallel improvement in health status and exercise tolerance.